RecruitingNot ApplicableNCT03117946
Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy
Sponsor
Centre Hospitalier Universitaire de Besancon
Enrollment
220 participants
Start Date
May 29, 2017
Study Type
INTERVENTIONAL
Conditions
Summary
The aim of this study is to evaluate modulation of anti-tumor T cell responses in cancer patients treated by concomitant radiochemotherapy (i-RTCT)
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is looking at how the immune system — specifically the cells that fight cancer — responds when lung cancer or head and neck cancer patients receive radiation and chemotherapy at the same time.
**You may be eligible if...**
- You have been diagnosed with non-small cell lung cancer, small cell lung cancer, or head and neck cancer (confirmed by a tissue biopsy)
- You are scheduled to receive radiation and chemotherapy together as your first treatment
- You are willing to sign a consent form
**You may NOT be eligible if...**
- You are scheduled for radiation alone, stereotactic radiation, or radiation given before and after chemotherapy (not at the same time)
- You have already received radiation and chemotherapy together for a previous cancer
- You are currently taking immunotherapy, chemotherapy, or other immune-suppressing medications
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERBiological samples
blood and tumor tissue sample
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03117946
Related Trials
To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.
NCT069702754 locations
A Study of a Side Effects and Resource Navigation Program for People With Cancer
NCT076468478 locations
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828761 locations
IDOV-Immune for Advanced Solid Tumors
NCT069106575 locations
Empathic Communication Skills (ECS) Training
NCT0545684112 locations